Statistics
Publications
2
Citations
60
H-Index
2
Active since
1996
Affiliations
Johnson & Johnson (United States)(Current)
Kenneth D. Krantz is an author at Johnson & Johnson (United States) specializing in pharmacology, impetigo treatment, and dose comparison groups.
Publications per year
1996–2011
2
2
Recombinant Human Erythropoietin (rHuEPO) for the Treatment of the Anemia of Cancer
Robert Abels, Kay Larholt, Kenneth D. Krantz et al. · The Oncologist · 1996 · 44 citations · Full text
NVC-422 topical gel for the treatment of impetigo.
Susan M Iovino, Kenneth D. Krantz, Daisy Blanco et al. · PubMed · 2011 · 16 citations · Full text
1–2 of 2